Clinical Trial Update: Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating intravitreal infliximab for diabetic retinopathy with choroidal neovascularization and macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Retina Research Foundation | Conditions: Diabetic Retinopathy, Macular Degeneration | Phase 1 | Status: UNKNOWN